New Delhi: The Coldrif cough syrup scandal, which claimed the lives of children in Madhya Pradesh, has now blown the lid off deep regulatory failures by the Tamil Nadu Food and Drug Administration (TNFDA).

Investigations by the Central Drugs Standard Control Organisation (CDSCO) have revealed that Sresan Pharma, the Kanchipuram-based manufacturer of the cough syrup, operated unchecked for over a decade despite its dismal infrastructure and multiple violations of national drug safety rules, the CDSCO sources told PTI.

Shockingly, a source says the company, licensed in 2011 by the TNFDA, was never part of any of the CDSCO databases.

The CDSCO's inspection exposed the unit's appalling conditions and total non-compliance with Good Manufacturing Practices (GMP), the sources said. "The CD

See Full Page